期刊文献+

肝细胞肝癌p21^(WAF1)与p53的表达及其意义 被引量:3

EXPRESSION AND SIGNIFICANCE OF p21^(WAF1) AND p53 IN HEPATIC CELL CARCINOMA
暂未订购
导出
摘要 目的 探讨HCC中p2 1WAF1与p5 3的表达及其意义。方法 应用免疫组化法检测 38例手术切取的HCC及其配对癌旁肝组织、5例正常肝组织中p2 1WAF1和p5 3的表达 ,并分析它们与病理形态的关系。结果 p2 1WAF1、p5 3在HCC中的表达明显高于癌旁肝组织 ,p2 1WAF1阳性 14例 (36 8% ) ,p5 3阳性 2 8例 (73 7% ) ,其中两者表达一致 (均阳或均阴 )的 18例 ,表达不一致的 2 0例。癌旁肝组织 1例 (2 6% )、正常肝组织 2例p2 1WAF1呈阳性表达 ,所有癌旁及正常肝组织中均未见p5 3表达。HCC中p2 1WAF1表达与p5 3表达无明显关系 (P >0 0 5 )。在不同组织学分级、有无肝内转移或门脉癌栓之间p2 1WAF1、p5 3表达差异均无显著性 (P >0 0 5 )。结论 p2 1WAF1与p5 3在癌内表达均高于癌旁 ,但两者间并无相关性 ,提示p2 1WAF1表达可能受p5 3依赖和p5 Objective To explore the expression and significance of p21 WAF1 and p53 in HCC. Methods Immunohistochemical method (IHC) was used to localize and semi quantitate the proteins of p21 WAF1 and p53 and to observe the relationship between the expression of p21 WAF1 and the different histopathologic characters in 38 patients of HCC and their peri cancer tissue as well as 5 normal liver tissue. Results Of all 38 cases, both p21 WAF1 and p53 expression were significantly higher in tumor than that in corresponding non tumors liver tissue; 14 (36 8 %) of 38 cases showed p21 WAF1 positive staining, 28 cases (73 7 %) were p53 positive, p21 WAF1 +/p53+ or p21 WAF1 /p53- were observed in 18, while 20 cases showed p53+/p21 WAF1 - or p53-/p21 WAF1 +. p21 WAF1 + was seen in 1 of 38 (2 6 %) corresponding non cancerous tissue and 2 of 5 normal liver tissue. p53 protein was not detected neither in the non tumorous tissue nor in normal liver. No significant association was found between the expressions of p21 WAF1 and p53( P >0 05) in HCC. Their was no significant correlation between p21 WAF1 or p53 expression and the different histopathologic characters of tumor (differentiating grades, intrahepatic metastasis and/or cancerous thrombi within portal veins). Conclusion Both p21 WAF1 and p53 proteins are over expressed in HCC than that in corresponding non tumorous liver tissue, but there is no relationship between them. Both p53 independent and p53 dependent mechanism may play a role in regulating p21 WAF1 expression in HCC. p21 WAF1 immunostaining cannot be used to assess the status of p53 in any given cell or tissue.
出处 《肿瘤》 CAS CSCD 北大核心 2001年第2期85-87,F003,共4页 Tumor
基金 国家"九五"科技攻关项目!(96 90 6 0 1 15 )资助
关键词 肝细胞癌 P21^WAF1 P53 基因产物 免疫组织化学 Liver neoplasma Carcinoma, hepatocellular Gene products, p21 WAF1 Gene products, p53 IHC
  • 相关文献

参考文献6

  • 1Hui A M,Hepatology,1997年,25卷,575页
  • 2Tron V A,Am J Pathol,1996年,149卷,1139页
  • 3Mc Donald Ⅲ E R,Cancer Res,1996年,56卷,2250页
  • 4Zhang W,Cancer Res,1995年,55卷,668页
  • 5Zhang H,Gene & Development,1994年,8卷,1750页
  • 6Xong Y,Nature,1993年,366卷,701页

同被引文献27

  • 1朱朝辉,邢诗安,程平,曾甫清,鲁功成.膀胱癌中p53突变及Bcl-2、PCNA表达与细胞的增殖和凋亡[J].华中科技大学学报(医学版),2004,33(5):582-585. 被引量:5
  • 2张艳玲,梁后杰,肖文华,阎晓初.细胞凋亡、PCNA、p53和Fas与肝细胞癌临床病理特征关系的研究[J].第三军医大学学报,2004,26(24):2191-2193. 被引量:5
  • 3朱波,欧超,罗元,曹骥,班克臣,焦杨,李瑗,苏建家.CyclinD1 c-myc和p53的表达与肝细胞癌生物学行为关系[J].中国肿瘤临床,2006,33(2):67-70. 被引量:13
  • 4成军主编.肿瘤相关基因[M].北京:北京医科大学出版社,1999.245-246.
  • 5Lukas J, Groshen S, Saffari B, et el. WAFI/CIPI gene polymorphysim and expression in carcinomas of the breast, ovary and endometrium. Am J Pathol, 1997;150( 1 ) : 167 -75.
  • 6Hui AM, Kanai Y, Sakamoto M, et al. Reduced p21 WAF1/CIP1 expression and p53 mutation in hepatoeellular careinomas[J].Hepatology, 1997 ; 25 : 575 - 579.
  • 7Furutani M, Arii S, Tanaja H, et al. Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma. Cancer Lett, 1997 ; 111 : 191.
  • 8Haupt Y, Maya R, Kazaz A, et al. MDM2 promotes the rapid degradation of p53[J]. Nature, 1997;387:296-299.
  • 9Momand J, Zambetti GP, Olson DC, et al. The mdm2 oncogene products forms a complex with the p53 protein and inhibits p53 mediated transactivation[J]. Cell, 1992;69:1237-1245.
  • 10Oliner JD, Pietenpol JA, Thiagalingan S, et al. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53[J].Nature, 1993;362:857-860.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部